摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3,4,7,8,9,10-hexahydro-2H-[1,3]thiazino[3,2-b]isoquinolin-6-one | 72570-49-1

中文名称
——
中文别名
——
英文名称
3,4,7,8,9,10-hexahydro-2H-[1,3]thiazino[3,2-b]isoquinolin-6-one
英文别名
6-oxo-3,4,7,8,9,10-hexahydro-2H,6H-1,3-thiazino[3,2-b]isoquinoline;3,4,7,8,9,10-hexahydro-2H-[1,3]thiazino[3,2-b]isoquinolin-6-one
3,4,7,8,9,10-hexahydro-2<i>H</i>-[1,3]thiazino[3,2-<i>b</i>]isoquinolin-6-one化学式
CAS
72570-49-1
化学式
C12H15NOS
mdl
——
分子量
221.323
InChiKey
XOXVYCPGPYCDKW-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.2
  • 重原子数:
    15
  • 可旋转键数:
    0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.58
  • 拓扑面积:
    45.6
  • 氢给体数:
    0
  • 氢受体数:
    2

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    KUBO KAZUO; ITO NORIKI; ISOMURA YASUO; SOZU ISAO; HOMMA HIROSHIGE; MURAKA+, YAKUGAKU DZASSI, JAKUGAKU ZASSNI, J. PHARM. SOS. JAR., 1979, 99, NO 9, 88+
    摘要:
    DOI:
  • 作为产物:
    描述:
    2-Cyanomethylene-cyclohexane-carboxylic acid ethyl ester 、 3-amino-propanethiol; hydrobromidesodium acetate邻二氯苯 为溶剂, 以of 6-oxo-3,4,7,8,9,10-hexahydro-2H,6H-1,3-thiazino[3,2-b]isoquinoline was obtained的产率得到3,4,7,8,9,10-hexahydro-2H-[1,3]thiazino[3,2-b]isoquinolin-6-one
    参考文献:
    名称:
    Novel fused derivatives of 2-pyridones
    摘要:
    该文描述了一种新型含氮杂环化合物,其化学式为 ##STR1## 其中R.sub.1和R.sub.2中的一个代表低碳基,苯基,卤代苯基或低碳基苯基,另一个代表氢原子,低碳基或苯基低碳基;R.sub.1和R.sub.2可以结合形成三亚甲基基团或四亚甲基基团;R.sub.3代表氢原子,低碳基,苯基或苯基低碳基;X代表氧原子,硫原子,亚胺基或由##STR2## 所示的基团,其中m代表1或2,R.sub.4代表低碳基,羟基低碳基,环烷基或苯基低碳基;Y代表乙烯基,可以被低碳基取代,三亚甲基基团,四亚甲基基团,可以被低碳基取代的乙烯基,或者##STR3## 其中R.sub.5代表氢原子,低碳基,三氟甲基基团或苯基;当R.sub.1和R.sub.2中的一个是低碳基,另一个是氢原子时,X是##STR4## ,Y是乙烯基,并且其药学上可接受的无毒盐。上述化合物是强烈的镇痛抗炎药物。
    公开号:
    US04186200A1
点击查看最新优质反应信息

文献信息

  • Nitrogen-containing heterocyclic compounds
    申请人:Yamanouchi Pharmaceutical Co., Ltd.
    公开号:US04251533A1
    公开(公告)日:1981-02-17
    Novel nitrogen-containing heterocyclic compounds shown by the formula ##STR1## wherein one of R.sub.1 and R.sub.2 represents a lower alkyl group, a phenyl group, a halophenyl group, or a lower alkoxyphenyl group and the other of them represents a hydrogen atom, a lower alkyl group, or a phenyl lower alkyl group; said R.sub.1 and R.sub.2 may combine with each other to form a trimethylene group or a tetramethylene group; R.sub.3 represents a hydrogen atom, a lower alkyl group, a phenyl group, or a phenyl lower alkyl group; X represents an oxygen atom, a sulfur atom, an imino group, or a group shown by ##STR2## wherein m represents 1 or 2 and R.sub.4 represents a lower alkyl group, a hydroxy lower alkyl group, a cycloalkyl group or a phenyl lower alkyl group; and Y represents an ethylene group which may be substituted by lower alkyl group, a trimethylene group, a tetramethylene group, a vinylene group which may be substituted by a lower alkyl group, or ##STR3## wherein R.sub.5 represents a hydrogen atom, a lower alkyl group, a trifluoromethyl group, or a phenyl group; said X is the group shown by ##STR4## when one of said R.sub.1 and R.sub.2 is a lower alkyl group and the other is a hydrogen atom, and said Y is an ethylene group, 1/7 and the pharmacologically acceptable non-toxic salts thereof. The compounds described above are strong analgesic anti-inflammatory agents.
    以下是翻译结果: 新颖的含氮杂环化合物,其化学式为##STR1##其中R.sub.1和R.sub.2中的一个代表低碳基,苯基,卤代苯基或低烷氧基苯基,另一个代表氢原子,低碳基或苯基低碳基;R.sub.1和R.sub.2可以结合形成三亚甲基基团或四亚甲基基团;R.sub.3代表氢原子,低碳基,苯基或苯基低碳基;X代表氧原子,原子,亚基团或由##STR2##所示的基团,其中m代表1或2,R.sub.4代表低碳基,羟基低碳基,环烷基或苯基低碳基;Y代表乙烯基,可以被低碳基取代,三亚甲基基团,四亚甲基基团,可以被低碳基取代的乙烯基,或##STR3##其中R.sub.5代表氢原子,低碳基,三甲基基团或苯基;当R.sub.1和R.sub.2中的一个是低碳基而另一个是氢原子时,X是由##STR4##所示的基团,Y是乙烯基,1/7和药理学上可接受的非毒性盐。上述化合物是强烈的镇痛抗炎剂。
  • Nitrogen-containing heterocyclic ring derivatives
    申请人:Yamanouchi Pharmaceutical Co., Ltd.
    公开号:US04284778A1
    公开(公告)日:1981-08-18
    Novel nitrogen-containing heterocyclic compounds shown by the formula ##STR1## wherein one of R.sub.1 and R.sub.2 represents a lower alkyl group, a phenyl group, a halophenyl group, or a lower alkoxyphenyl group and the other of them represents a hydrogen atom, a lower alkyl group, or a phenyl lower alkyl group; said R.sub.1 and R.sub.2 may combine with each other to form a trimethylene group or a tetramethylene group; R.sub.3 represents a hydrogen atom, a lower alkyl group, a phenyl group, or a phenyl lower alkyl group; X represents an oxygen atom, a sulfur atom, an imino group, or a group shown by ##STR2## wherein m represents 1 or 2 and R.sub.4 represents a lower alkyl group, a hydroxy lower alkyl group, a cycloalkyl group or a phenyl lower alkyl group; and Y represents an ethylene group which may be substituted by a lower alkyl group, a trimethylene group, a tetramethylene group, a vinylene group which may be substituted by lower alkyl group, or ##STR3## wherein R.sub.5 represents a hydrogen atom, a lower alkyl group, a trifluoromethyl group, or a phenyl group; said X is the group shown by ##STR4## when one of said R.sub.1 and R.sub.2 is a lower alkyl group and the other is a hydrogen atom, and said Y is an ethylene group, and the pharmacologically acceptable non-toxic salts thereof. The compound described above are strong analgesic anti-inflammatory agents.
    这是一种新型含氮杂环化合物,其化学式为##STR1##其中R.sub.1和R.sub.2中的一个代表较低的烷基、苯基、卤代苯基或较低的烷氧基苯基,另一个代表氢原子、较低的烷基或苯基较低烷基;R.sub.1和R.sub.2可以结合形成三亚甲基基团或四亚甲基基团;R.sub.3代表氢原子、较低的烷基、苯基或苯基较低烷基;X代表氧原子、原子、亚胺基或由##STR2##所示的基团,其中m代表1或2,R.sub.4代表较低的烷基、羟基较低烷基、环烷基或苯基较低烷基;Y代表乙烯基,可以被较低的烷基、三亚甲基基团、四亚甲基基团、可以被较低烷基取代的乙烯基或由##STR3##所示的基团取代;R.sub.5代表氢原子、较低的烷基、三甲基基团或苯基;当R.sub.1和R.sub.2中的一个是较低的烷基,另一个是氢原子时,X是由##STR4##所示的基团,Y是乙烯基,且其药理学上可接受的无毒盐。上述化合物是强的镇痛和抗炎药物。
  • US4186200A
    申请人:——
    公开号:US4186200A
    公开(公告)日:1980-01-29
  • US4251533A
    申请人:——
    公开号:US4251533A
    公开(公告)日:1981-02-17
  • US4284778A
    申请人:——
    公开号:US4284778A
    公开(公告)日:1981-08-18
查看更多